Why the study?
Does Angiotensin II induce cardiac metabolic inefficiency and insulin resistance via PDK4 in a mouse model of hypertrophy?
Population
Wild-type and PDK4-deleted mice in an ANG II-induced cardiac hypertrophy model
Comparison
Angiotensin II treatment and/or PDK4 deletion vs Vehicle-treated mice
Design
Preclinical
Authors
Loading...
PDK4 inhibition merits testing in diastolic dysfunction models; leaves open translation to human heart failure therapy.
Does Angiotensin II induce cardiac metabolic inefficiency and insulin resistance via PDK4 in a mouse model of hypertrophy?
ANG II induces cardiac metabolic inefficiency and insulin resistance via increased PDK4 levels, highlighting a critical mechanistic pathway in heart failure.
Mori et al. (2013) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: